Related references
Note: Only part of the references are listed.Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene
Ken Dutton-Regester et al.
GENES CHROMOSOMES & CANCER (2012)
Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing
Mitchell S. Stark et al.
NATURE GENETICS (2012)
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
Sergey I. Nikolaev et al.
NATURE GENETICS (2012)
Delving into somatic variation in sporadic melanoma
Vijay Walia et al.
PIGMENT CELL & MELANOMA RESEARCH (2012)
The genetics of uveal melanoma: an emerging framework for targeted therapy
J. William Harbour
PIGMENT CELL & MELANOMA RESEARCH (2012)
Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines
Kevin C. H. Ha et al.
BMC MEDICAL GENOMICS (2011)
Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples
Serban Nacu et al.
BMC MEDICAL GENOMICS (2011)
Proinvasion Metastasis Drivers in Early-Stage Melanoma Are Oncogenes
Kenneth L. Scott et al.
CANCER CELL (2011)
Dominantly Inherited Constitutional Epigenetic Silencing of MLH1 in a Cancer-Affected Family Is Linked to a Single Nucleotide Variant within the 5′UTR
Megan P. Hitchins et al.
CANCER CELL (2011)
Functional Parsing of Driver Mutations in the Colorectal Cancer Genome Reveals Numerous Suppressors of Anchorage-Independent Growth
Ugur Eskiocak et al.
CANCER RESEARCH (2011)
MEK-Independent Survival of B-RAFV600E Melanoma Cells Selected for Resistance to Apoptosis Induced by the RAF Inhibitor PLX4720
Chen Chen Jiang et al.
CLINICAL CANCER RESEARCH (2011)
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg et al.
CLINICAL CANCER RESEARCH (2011)
Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing
Dorothee Pflueger et al.
GENOME RESEARCH (2011)
Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
Nikhil Wagle et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
High-throughput RNAi Screening Identifies a Role for TNK1 in Growth and Survival of Pancreatic Cancer Cells
Meredith C. Henderson et al.
MOLECULAR CANCER RESEARCH (2011)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D. Morin et al.
NATURE (2011)
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikos I. Poulikakos et al.
NATURE (2011)
The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset
Craig J. Ceol et al.
NATURE (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
Yaoting Gui et al.
NATURE GENETICS (2011)
Exome sequencing identifies GRIN2A as frequently mutated in melanoma
Xiaomu Wei et al.
NATURE GENETICS (2011)
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
Kai Wang et al.
NATURE GENETICS (2011)
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma
Meng Li et al.
NATURE GENETICS (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor
Glen M. Boyle et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
A Melanoma Molecular Disease Model
Smruti J. Vidwans et al.
PLOS ONE (2011)
Epigenetic Regulation of MicroRNA Genes and the Role of miR-34b in Cell Invasion and Motility in Human Melanoma
Joseph Mazar et al.
PLOS ONE (2011)
Cross-Platform Array Screening Identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as Genes Frequently Silenced by Methylation in Melanoma
Vanessa F. Bonazzi et al.
PLOS ONE (2011)
Mutagen-Specific Mutation Signature Determines Global microRNA Binding
Eyal Greenberg et al.
PLOS ONE (2011)
Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
Sameek Roychowdhury et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Functional Viability Profiles of Breast Cancer
Rachel Brough et al.
CANCER DISCOVERY (2011)
International Cancer Genome Consortium Data Portal-a one-stop shop for cancer genomics data
Junjun Zhang et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2011)
Identification of fusion genes in breast cancer by paired-end RNA-sequencing
Henrik Edgren et al.
GENOME BIOLOGY (2011)
Protein interaction network topology uncovers melanogenesis regulatory network components within functional genomics datasets
Hsiang Ho et al.
BMC SYSTEMS BIOLOGY (2010)
Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
Jessie Villanueva et al.
CANCER CELL (2010)
An Integrated Approach to Uncover Drivers of Cancer
Uri David Akavia et al.
CELL (2010)
Integrative analysis of the melanoma transcriptome
Michael F. Berger et al.
GENOME RESEARCH (2010)
A comprehensive catalogue of somatic mutations from a human cancer genome
Erin D. Pleasance et al.
NATURE (2010)
The histone variant macroH2A suppresses melanoma progression through regulation of CDK8
Avnish Kapoor et al.
NATURE (2010)
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Cory M. Johannessen et al.
NATURE (2010)
Melanomas acquire resistance toB-RAF(V600E) inhibition by RTK or N-RAS upregulation
Ramin Nazarian et al.
NATURE (2010)
International network of cancer genome projects
Thomas J. Hudson et al.
NATURE (2010)
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
Nallasivam Palanisamy et al.
NATURE MEDICINE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Characterization of the Melanoma miRNAome by Deep Sequencing
Mitchell S. Stark et al.
PLOS ONE (2010)
Frequent MAGE Mutations in Human Melanoma
Otavia L. Caballero et al.
PLOS ONE (2010)
MEK1 mutations, but not ERK2 mutations, occur in melanomas and colon carcinomas, but none in thyroid carcinomas
Avaniyapuram Kannan Murugan et al.
CELL CYCLE (2009)
Genome-wide screen of promoter methylation identifies novel markers in melanoma
Yasuo Koga et al.
GENOME RESEARCH (2009)
Molecular Profiling of the Plexinome in Melanoma and Pancreatic Cancer
Asha Balakrishnan et al.
HUMAN MUTATION (2009)
Increasing Burden of Melanoma in the United States
Eleni Linos et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma
Michael G. Gartside et al.
MOLECULAR CANCER RESEARCH (2009)
Transcriptome sequencing to detect gene fusions in cancer
Christopher A. Maher et al.
NATURE (2009)
Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples
Laura E. MacConaill et al.
PLOS ONE (2009)
MEK1 mutations confer resistance to MEK and B-RAF inhibition
Caroline M. Emery et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor
Miguel F. Segura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
RNAi screen for rapid therapeutic target identification in leukemia patients
Jeffrey W. Tyner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A novel AKT3 mutation in melanoma tumours and cell lines
M. A. Davies et al.
BRITISH JOURNAL OF CANCER (2008)
Modeling genomic diversity and tumor dependency in malignant melanoma
William M. Lin et al.
CANCER RESEARCH (2008)
The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms
Federica Felicetti et al.
CANCER RESEARCH (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Nonsynonymous somatic mitochondrial mutations occur in the majority of cutaneous melanomas
Suhail K. Mithani et al.
MELANOMA RESEARCH (2008)
Genome-Wide siRNA-Based Functional Genomics of Pigmentation Identifies Novel Genes and Pathways That Impact Melanogenesis in Human Cells
Anand K. Ganesan et al.
PLOS GENETICS (2008)
Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays
Mitchell Stark et al.
CANCER RESEARCH (2007)
High-throughput oncogene mutation profiling in human cancer
Roman K. Thomas et al.
NATURE GENETICS (2007)
Brief report:: Inheritance of a cancer-associated MLH1 germ-line epimutation
Megan P. Hitchins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer
Tsun Leung Chan et al.
NATURE GENETICS (2006)
Somatic activation of KIT in distinct subtypes of melanoma
John A. Curtin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
microRNAs exhibit high frequency genomic alterations in human cancer
Lin Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Mutations of PIK3CA are rare in cutaneous melanoma
K Omholt et al.
MELANOMA RESEARCH (2006)
Cutaneous melanoma susceptibility and progression genes
FA de Snoo et al.
CANCER LETTERS (2005)
A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer
P Stephens et al.
NATURE GENETICS (2005)
TFG is a novel fusion partner of NORI in extraskeletal myxoid chondrosarcoma
M Hisaoka et al.
GENES CHROMOSOMES & CANCER (2004)
Large-scale identification and characterization of human genes that activate NF-κB and MAPK signaling pathways
A Matsuda et al.
ONCOGENE (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)